Status:

COMPLETED

Fractional CO2 Laser Therapy in Minimizing Genitourinary Syndrome of Menopause in Gynecological Cancer Survivors

Lead Sponsor:

Ohio State University Comprehensive Cancer Center

Conditions:

Cervical Carcinoma

Dyspareunia

Eligibility:

FEMALE

Phase:

NA

Brief Summary

This randomized pilot trial studies how well fractional carbon dioxide (CO2) laser therapy works in minimizing genitourinary syndrome of menopause (GSM) in gynecological cancer survivors. Fractional C...

Detailed Description

PRIMARY OBJECTIVES: I. To conduct a pilot trial to estimate the proportion of gynecologic cancer patients with vaginal dryness or dyspareunia, who will have an improvement in their symptoms with vagi...

Eligibility Criteria

Inclusion

  • Women with cervical, endometrial, vaginal, vulvar or ovarian cancer who have completed all cancer related treatment \>= 6 months prior to enrollment
  • Any form of hysterectomy, including radical hysterectomy permitted
  • Must have no evidence of recurrent disease on pelvic exam within past 3 months
  • Radiation therapy is permitted but not required
  • Patient reported dyspareunia and/or vaginal dryness with severity of \>= 4 on a scale from 0 (none) to 10 (most severe) that has been persistent over \>= 4 weeks and/or the inability to be sexually active due to pain

Exclusion

  • Patients with recurrent or metastatic endometrial, vaginal, vulvar, cervical, or ovarian cancer
  • Pelvic organ prolapse stage II or higher
  • Prior reconstructive pelvic surgery involving mesh
  • Hormone replacement therapy or vaginal estrogen therapy within 6 weeks prior to enrollment

Key Trial Info

Start Date :

May 11 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 12 2022

Estimated Enrollment :

19 Patients enrolled

Trial Details

Trial ID

NCT03372720

Start Date

May 11 2018

End Date

April 12 2022

Last Update

April 22 2022

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Johns Hopkins University

Baltimore, Maryland, United States, 21287

2

Mayo Clinic

Rochester, Minnesota, United States, 55905

3

Sanford Roger Maris Cancer Center

Fargo, North Dakota, United States, 58104

4

Ohio State University Comprehensive Cancer Center

Columbus, Ohio, United States, 43210